BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38660844)

  • 21. [Induction of apoptosis of the human leukemia cells by arctigenin and its mechanism of action].
    Wang L; Zhao F; Liu K
    Yao Xue Xue Bao; 2008 May; 43(5):542-7. PubMed ID: 18717345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of jiedu huayu recipe containing serum on the expressions of survivin and NF-kappaB of K562/A02 cell apoptosis by].
    Ma WK; Li YY; Yao XM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1097-100. PubMed ID: 21910343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of PI3Kδ inhibitor idelalisib on proliferation of human myeloid leukemia cells and the reversal effect on drug resistance to adriamycin.
    Li K; Yi P; Luo H; Li J; Meng L; Tang M; Zeng W; Yang S; Wang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1389-1397. PubMed ID: 33472993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of tetrandrine on nuclear factor-kappaB expression in leukemia multidrug-resistant cell line K562/A02].
    Chen BA; Su AL; Cheng J; Zhao HH; Li GH; Wang XM
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):956-9. PubMed ID: 18782542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
    Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells].
    Xiao XB; Xie ZX; Qin Q
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):422-5. PubMed ID: 17152486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms.
    Zhao D; Jiang Y; Dong X; Liu Z; Qu B; Zhang Y; Ma N; Han Q
    Biomed Pharmacother; 2011 Aug; 65(5):354-8. PubMed ID: 21775093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
    Pan J; Miao D; Chen L
    Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isoalantolactone Inhibits Proliferation of K562/A02 Cells through Caspase-Dependent Apoptotic Pathway].
    Guan YH; Zhang XD; Cai H; Yang CH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):110-114. PubMed ID: 28245385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of compound Zhe-Bei granule (CZBG) combined with doxorubicin on cell apoptosis and expression of related proteins in K562/A02 multidrug resistance tumor xenografts in mice].
    Chen XY; Zheng Z; Chen J; Li DY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1439-42. PubMed ID: 20030922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of PLK1 gene silence on cell cycle, proliferation and drug resistance in K562/A02 cells].
    Liu L; Zhang M; Zou P; Tian L; Liu F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):241-6. PubMed ID: 16638189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of small interfering RNA targeting multidrug resistance-related protein and bcl-2 on drug resistance and apoptosis of K562 and K562/ADM cells].
    Song ZY; Hu HY; Deng L; Wu BY; Guo KY; Zhang MX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1306-8. PubMed ID: 18676285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [miR-515-5p targeting Toll-like receptor 4 regulates myeloid differentiation primary response gene 88/nuclear factor-kappa B pathway to inhibit apoptosis and inflammatory response of osteoarthritis chondrocytes].
    Cai D; Yang Z; Zhong C; Zhang J; Hong S
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 Mar; 38(3):315-323. PubMed ID: 38500425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
    Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
    Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDR reversal activity of bromotetrandrine in vitro and in vivo.
    Cheng J; Wang JQ; Chen BA; Gao F; Xu WL; Shen HL; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Song HH; Bao W; Sun Q; Dai YY; Sun XC; Cheng HY; Deng YX; Li GH; Chen NN; Liu LJ; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1183-91. PubMed ID: 19840447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The Role and Mechanism of MiR-451 in Multidrug Resistance of Leukemia Cell Line K562/A02].
    Feng YL; Su BX; Ge FM; Dai CW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):685-692. PubMed ID: 37356927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].
    Han YQ; Yuan JY; Shi YJ; Zhu Y; Wu SL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):604-8. PubMed ID: 14706144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells.
    Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM
    Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of Shikonin on Autophagy and Apoptosis of Human Promyelocytic Leukemia Cells].
    Chen Y; Xie XM; Zhang XL; Zhang XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):416-421. PubMed ID: 38660845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.